The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 14, 2019

Filed:

May. 01, 2015
Applicant:

Princeton Trade & Technololgy, Inc., Princeton, NJ (US);

Inventors:

Mohamed E. Labib, Princeton, NJ (US);

Stanislav S. Dukhin, Goldens Bridge, NY (US);

Assignee:

Novaflux Inc., Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/00 (2006.01); A61M 31/00 (2006.01); A61L 27/58 (2006.01); A61L 27/54 (2006.01); A61L 31/16 (2006.01); A61L 31/14 (2006.01); A61L 31/04 (2006.01); A61L 27/56 (2006.01); A61F 11/00 (2006.01);
U.S. Cl.
CPC ...
A61F 11/002 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61L 27/58 (2013.01); A61L 31/04 (2013.01); A61L 31/146 (2013.01); A61L 31/16 (2013.01); A61F 2/0077 (2013.01); A61F 2250/0067 (2013.01); A61F 2250/0068 (2013.01); A61L 2300/21 (2013.01); A61L 2300/406 (2013.01); A61L 2300/41 (2013.01); A61L 2300/602 (2013.01); A61L 2430/14 (2013.01); A61M 31/002 (2013.01);
Abstract

A tympanostomy tube containing a polymeric material and a drug is described. The polymeric material may comprise a non-resorbable polymer and a water-soluble polymer. The drug may be released when the device is contacted by an aqueous liquid such as middle ear exudate during otitis media. The implant may contain sufficient drug to treat multiple episodes of otitis media or to catch subsequent episodes in their early stages as a prophylactic. The device may be hydrophilic and further may contain a surfactant. The implant may be porous. The implant may have enhanced surface area at places exposed to middle ear liquid and may have enlarged mass so as to contain an increased total amount of drug. Intentional reorientation of the patient's head may aid in moving drug-containing liquid around the middle ear cavity. Similar implants can be used in other mucosal cavities.


Find Patent Forward Citations

Loading…